|Articles|September 15, 2008

PerkinElmer and M. D. Anderson Cancer Center Collaborate

PerkinElmer, Inc. (Waltham, Massachusetts) announced an arrangement with the University of Texas M. D. Anderson Cancer Center (Houston, Texas) that will bring the company's Array Comparative Genomic Hybridization technique to the cancer center.

PerkinElmer, Inc. (Waltham, Massachusetts) announced an arrangement with the University of Texas M. D. Anderson Cancer Center (Houston, Texas) that will bring the company's Array Comparative Genomic Hybridization technique to the cancer center. PerkinElmer reportedly will train the facility?s Molecular Genetic Technology students in the technique. The company will also support two student research projects for presentation at genomics and cytogenetics conferences.


Related to this article

LC-MS/MS Method Detects Propofol via Metabolite
Koji Yamaguchi of the International University of Health and Welfare (Narita, Japan) discusses a novel derivatized liquid chromatography-tandem mass spectrometry (LC-MS/MS) method plus propofol glucuronide (PRG) marker which improves forensic propofol detection.